of occlusion. Generally, one distinguishes between either thrombus or occlusive dissection, but often the mechanism is indeterminate.
Thrombus formation was thought to be the predominant mechanism in 19 % to 33 % of patients, dissection in 26 % , and the combination in 7 % , whereas in 42 % it was not possible to establish the underlying cause.5v6 These findings clearly reflect the inability of angiography to reliably detect intracoronary abnormalities. Newer intracoronary imaging techniques such as intracoronary ultrasound imaging and angioscopy may be useful in establishing the mechanisms and helpful in guiding optimal management.
Incidence of abrupt occlusion. Abrupt coronary occlusion was defined as clinical or electrocardiographic evidence of myocardial ischemia and a complete (Thrombolysis In Myocardial Infarction [TIMI grade 01) or critical reduction (TIM1 grades 1 or 2) in coronary blood flow of a previously patent (TIM1 grades 2 or 3) coronary vessel segment occurring during or after coronary intervention within the period of hospitalization.
Abrupt coronary occlusion of a previously totally occluded artery was defined as reclosure (TIM1 grades 0 or 1) after establishment of TIM1 grade 3 flow during initial successful intervention; this reclosure may be associated with ischemia. The reported incidence of abrupt coronary occlusion during and after coronary intervention ranges from 4.4 % to 8.3%) with an average of 5.7 % l-7 (Table I) .
Predictors of abrupt coronary occlusion. For optimal clinical decision-making and patient counseling, it would be desirable if one could identify preprocedural and procedural high-risk procedures. Several predictors for acute coronary occlusion have been identified (Table II) , but unfortunately they generally have a low positive or negative predictive value.3-5,8> 13-16 However, the make-up of a risk profile for each patient is often helpful and allows a crude estimation of the potential risk, such that in case of (35) 18 (33) 56 (Wt 78 (55)t 49 (40) 49 (40) 37 (36) 30 (31) 22 (20) 25 (23) 9 (33) 11 (41) 192 (35) 211 (38) AMI, Acute myocardial infarction; CAEG, coronary artery bypass grafting; NHLBI, National Heart, Lung, and Blood Institute; PTCA, percutaneous transluminal coronary angioplasty. *Acute occlusion + major dissection causing complications. @ubgroup analysis of 140 patients with suitable review angiograms. the absence of any risk factor the probability of acute occlusion is very low (2 % ), whereas the presence of one or more risk factors clearly increases the probability of acute coronary occlusion. In case of the presence of three risk factors,5 this may add up to a 25 % probability.5
Obviously, identification of risk factors predictive of procedural death is important. It appears that procedural death is closely related to the presence of a large amount of myocardium at risk, although the extent of preexisting nonviable myocardium should also be considered. Predictors of death are left main coronary artery disease, collaterals originating from the attempted dilated vessel, severely compromised left ventricular function, and female sex.8j l7 Adequate prediction of the likelihood of acute occlusion has important consequences for the surgical standby. Patients with excessive risk for balloon angioplasty should be referred for elective bypass surgery. High-risk patients require active surgical standby, whereas medium and low-risk patients require only passive surgical standby.
MANAGEMENT
The recently proposed 1988 American College of In-hospital outcome of acute coronary occlusion.
In Cardiology/American Heart Association (AC C/AHA) the very early experience of percutaneous translumiTask Force classification scheme that categorizes lenal coronary angioplasty (PTCA), acute coronary sions into types A, B, and C was developed to classify occlusion complicating PTCA was traditionally patients with high, medium, and low risk. 0peration.l However, as experience accumulated, it became established practice, after first ruling out the possibility of acute occlusive coronary spasm with intracoronary nitroglycerin, to perform immediate redilation.18t lg Successful initial redilation can be achieved in an average of 44 % of patients (Table III) . Although the reopening is sustained in the majority of patients, in a few patients reocclusion with death, myocardial infarction, and the need for emergency surgery occurs (Table III) . When initial redilation was unsuccessful and thrombus formation appeared, adjunctive thrombolytic treatment, in combination with repeated dilation, was given. The outcome of this combined approach is displayed in Table IV ; the average success rate was 65 % .51 16-23 Failure of this combined treatment cannot totally be attributed to failure of thrombolytic therapy, but should also be ascribed to the difficulty in differentiating between dissection and thrombus using angiography. New intracoronary imaging techniques such as intracoronary angioscopy should be able to better distinguish between these mechanisms and should facilitate the management of these patients.
Emergency surgery after failed PTCA has been shown to be associated with a high mortality (aver- 52 (26) 13 (6.5) 37 (46) 2 (2.5) 50 (44) 13 (11) 8 (11.4) 4 (5.7) 91 (21) 6 (1.4) 27 (51) 2 (4.0)
Abbreviations as i n Tables I and III. *Selected were studies that i ncl uded patients with more than 500 angioplasty procedures.
age 4.2 % ), and the progression to a myocardial infarction can not be prevented in 28 % of patients on average (Table V) .24-2g The main feature that correlated best with perioperative death and myocardial infarction after acute surgery for complicated angioplasty appeared to be ongoing ischemia and hemodynamic instability. 3o The overall outcome of the management of acute occlusion using either redilation or a combination of thrombolytics and, in case of (26) 40 (74) 0 (0) 18 (33) 31 (57) 8 (15) 19 (35) 1 (2.0) NHLBI-PTCA II4 122 20 (16) 103 (84) 0 (0) 43 (35) 60 (49) 9 (7) 48 (39) 6 (5.0) Thorax Center5 104 5 (5) 95 (91) 34 (33) 31 (30) 56 (54) 4 (4) 37 (36) 6 (6.0) Ann Arbor6 109 0 (0) 98* (90) 42 (39) 25 (23) 61 (56) 17 (16) 22 (20) 9 (8.0) Totals (average) 389 39 (10) 336 (87) 76 (20) 117 (30) 208 (53) 38 (10) 126 (33) 22 (5.7)
Abbreviations as in Tables I and III . *In 11 of 109 patients other techniques (stent nine; atherectomy nine) were employed. tSuccess was defined as a successful reopened vessel or successful CABG without the occurrence of death or myocardial infarction. Table VI . The incidence of death after acute occlusion was an average 5.7 % , and a myocardial infarction occurred in 33 % of the patients. The average success rate was 53 % (success being defined as an open vessel or successful bypass surgery without the occurrence of death or myocardial infarction).
Prolonged balloon inflations. Prolonged balloon inflations may improve the immediate result after PTCA because a long inflation time may improve remodeling of the atherosclerotic obstruction or may "tack-up" a coronary occlusive flap. It is important to note, however, that long-lasting inflations cannot always be tolerated by the patient. Catheter reperfusion techniques have made it possible to perform long inflations while keeping the patient perfused, and they also allow initial ischemic, hemodynamic stabilization as a "bridge" to immediate surgery.31* 32 In selected patients, it was possible to obtain a satisfactory result with long-lasting inflations using the autoperfusion catheter. 33, 34 It should be noted, however, that it is not always possible to use autoperfusion catheters because vessels are small in caliber, tortuous, the lesions are angulated, or thrombus appears to play a significant role. The rather low efficacy of the "standard" management of acute coronary occlusion including redilation (even with longlasting inflations and a bigger balloon) thrombolytic treatment and emergency surgery has prompted the search for more effective treatment modalities. Bail-out stenting for treatment of refractory acute coronary occlusion. Acute symptomatic occlusion refractory to repeat dilatation with or without adjunctive pharmacologic treatment is one of the most troublesome situations one may encounter during coronary angioplasty. A technique capable of restoring and maintaining antegrade flow, stabilizing the clinical condition, and obviating the need for emergency bypass surgery would be most welcome. Intracoronary stent implantation prevents vessel collapse and tacks back intimal and medial tears, sealing the thrombogenic subintimal space. Clinical experience with bail-out stent implantation was first reported by Sigwart et a1. 35 In a very limited number of patients, the self-expanding Wallstent was implanted, which resulted in an immediate restoration of adequate coronary flow, with normalization of the electrocardiogram (ECG) and relief of symptoms with no evidence of acute myocardial infarction. Since then, each of the current clinically available stents has been used for this purpose with encouraging results (Table VII) . 35-42 A high implantation success rate is reported, which is remarkable when one takes into account the technical difficulties that may be encountered in a bail-out situation. Disappearance of angiographic landmarks and spasm of the vessel segment may make stent delivery and correct positioning very laborious. Data from randomized studies proving the superiority of stenting over other techniques or devices are lacking. It appears that bail-out stenting reduces the need for emergency bypass surgery and decreases the incidence of acute myocardial infarction (Table VII) . [35] [36] [37] [38] [39] [40] [41] [42] The results compare very favorably with those after abrupt closure following angioplasty without the use of bail-out stenting. This has prompted the recommendation that intracoronary stents should be available in all centers for bailout procedures.
A not totally resolved issue remains whether one should use a bail-out stent in situations associated with intracoronary thrombus formation, such as in patients with unstable angina or thrombotic abrupt occlusions. A case can be made for implanting a stent in association with the administration of thrombolytic treatment. It may be expected that the stent induces brisk coronary flow, whereas intense thrombolytic treatment dissolves remaining clot and anticoagulation prevents clot formation. Thrombolytic treatment has also been advocated if there is a high suspicion of clot formation within the stented area after bail-out stent implantation. The incidence of subacute stent thrombosis has been reported to vary between 9% and 18% (on average, 15%) following bail-out stent implantation. To avoid stent thrombosis, an intensive and meticulous anticoagulation effort is necessary. This in turn exposes the patient to an increased risk of serious bleeding complications including intracranial bleeding in 0.5 % , gastrointestinal bleeding in 2.8%) and groin bleeding in 7.5%. Pseudoaneurysm at the puncture site occurs in 4.2 % of patients. There are no clear guidelines with respect to the decision to refer the patient for semielective bypass surgery after successful bail-out stent implantation. This decision should be based on a number of factors such as the clinical status of the patient after stenting (relief of angina, normalization of the ECG, or hemodynamic parameters), angiographic factors (acquired TIM1 flow, presence or absence of intracoronary thrombus, complete or incomplete covering of the dissection, residual stenosis, territory at risk, presence or absence of collaterals), procedural factors (number and size of stents used), and the indication for bail-out stent implantation (suboptimal result versus threatened or frank vessel closure).
Acute coronary occlusion after new techniques. New interventional techniques such as directional atherectomy, the excimer laser, or rotational ablation have been developed to overcome some of the limitations of conventional balloon angioplasty. Unfortunately, these new techniques, although having the potential to be more effective in lesions where the balloon is limited, are associated with specific complications, in addition to the invariable occurrence of acute coronary occlusion and its related sequelae (Table  VIII) .43-45 Directional rotational ablation is associated with the no-flow phenomenon (up to 17 %) and the excimer laser is associated with coronary vessel perforation (3.0 % ). 46 In particular, bifurcation lesions and discrete noncalcific lesions have been shown to be associated with a higher likelihood of perforation with the excimer laser. It appears that the occurrence of acute closure and its related major complications is similar to that in balloon angioplasty, except for rotational coronary ablations, which appear to be associated with. a high myocardial infarction rate (8.6%), albeit the majority of these instances were non-Q wave infarctions (7.1%). Current management of acute coronq occlusion. Crucial to the management of acute coronary occlusion is the necessity to keep the ischemic period as short as possible. Valuable time should not be wasted by cumbersome attempts to recross the lesion or to repeat unsuccessful dilatations, or to use techniques unfamiliar in the bperator's catheterization laboratory. First, measures should be taken to relieve the pain and anxiety. One of the most important decisions one must make is whether the patient should be referred for emergency bypass surgery or whether a percutaneous technique should be selected (Fig. lj be lost and the myocardium should be revascularized as soon as possible. If one has decided in favor of an attempt with a percutaneous technique such as is the case in the majority of patients, in particular if the guide wire is still across the lesion, one performs an immediate inflation (short or long-lasting) with the same or a bigger balloon or with the use of an autoperfusion balloon. If this fails and occlusive dissection appears the cause, one should now consider the implantation of a bail-out stent. Bail-out stent implantation is preferred above other new techniques (laser, directional coronary atherectomy [DCA]) because of its more general acceptance, wider availability, and proven efficacy. Again, it is important not to waste valuable time. Prompt stent placement is associated with a low incidence of both myocardial infarction and the need for emergency bypass surgery.47 However, stent implantation is precluded in the various situations listed in Table X ; in these situations' it is probably wiser to refer the patient for emergency bypass surgery or, if thrombus formation is thought to play an important role, one may first attempt to reopen the vessel with adjunctive thrombolytic therapy. In hemodynamically unstable or life-threatening situations (left main artery occlusion or a very proximal, large left anterior descending artery), insertion of an intraaortic balloon pump or, if available, a percutaneous cardiopulmonary support device, should stabilize the patient and permit either a definite "work-up" of the acute occlusion or serve as a bridge until emergency surgery.
Conclusions. It is difficult to predict worse outcome during coronary intervention in an individual patient. The recently proposed AHAIACC classification to predict success and complication rate appears outdated. A new updated classification should be devised, based on lesion-specification that will allow classification of patients into high-, medium-, and low-risk groups. Ultravascular ultrasound will provide lesion-specific information that may either guide the use of specific devices or predict worse outcome. Newer techniques for specific lesions are expected to decrease acute complications. In case of acute occlusion, the use of angioscopy or intravascular ultrasound imaging will provide a better explanation of the direct underlying cause of the acute occlusion. Differentiation between dissection and thrombosis, and better delineation of the depth and extent of a dissection will increase our strategies to manage acute occlusion. Recoil or frank dissection will more readily be treated by intracoronary stenting techniques and we will be able to prevent or reverse acute occlusion in a substantial number of patients. The availability of more potent antiplatelet aggregation drugs, or newer anticoagulant drugs such as specific antithrombins, may provide options that may help us more effectively treat or prevent the occurrence of acute coronary occlusion. However, taking into account that the indications for coronary intervention are expected to expand, that these new cases will be associated with a higher likelihood of acute coronary occlusion, and that not all cases of acute occlusion can be reversed with percutaneous techniques, emergency surgery will still be needed. It is our opinion that a hospital with an interventional program should fulfil the following requirements: (1) guarantee the presence of operators familiar with long-lasting inflation and autoperfusion catheter techniques and (2) provide immediate access to a surgical back-up facility. In addition, such a facility should preferably have (1) operators skilled in bail-out stent techniques or (2) availability of an intraaortic balloon pump or percutaneous cardiopulmonary support device.
SUMMARY
Acute coronary occlusion occurs in 4.3 % to 8.3 % of patients during coronary angioplasty. Its occurrence is difficult to predict in an individual patient. At high risk are patients with unstable angina, intracoronary thrombus, extreme age, long complex lesions, and diffuse disease. "Standard" management including redilation (prolonged perfusion) thrombolytic treatment and emergency bypass surgery is only successful in approximately 50% of the patients and is associated with a high mortality and myocardial infarction rate of <6 % and 30%) respectively. Bail-out stent implantation appears to emerge as an effective alternative in suitable patients and might reduce mortality, the apparent progression to myocardial infarction, or might decrease the need for emergency bypass. New techniques including directional atherectomy, rotational ablation, or the excimer laser are associated with a similar frequency of acute occlusion. Immediate access to a surgical back-up facility remains necessary to treat refractory acute occlusions. 252-5.
